These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The relative activity of prostacyclin (PGI2) and a stable analogue 6beta-PGI1 on the gastrointestinal and cardiovascular systems. Whittle BJ; Boughton-Smith NK; Moncada S; Vane JR J Pharm Pharmacol; 1978 Sep; 30(9):597-9. PubMed ID: 29109 [No Abstract] [Full Text] [Related]
5. [Protection of the gastric mucosa by prostaglandins--is this physiologic concept suitable for ulcer therapy?]. Schepp W Leber Magen Darm; 1986 Jan; 16(1):41-50. PubMed ID: 3959724 [No Abstract] [Full Text] [Related]
6. [Prostaglandins and the gastric mucosa barrier]. Molinari F; Parodi MC Recenti Prog Med; 1982 Oct; 73(4):363-7. PubMed ID: 7156464 [No Abstract] [Full Text] [Related]
7. Cimetidine and prostaglandin prevent damage to gastric mucosa. Guth PH; Kauffman GL; Grossman MI Gastroenterology; 1978 Nov; 75(5):927-8. PubMed ID: 700336 [No Abstract] [Full Text] [Related]
8. [Analogs of prostaglandin-related substances and inhibitors of their formation and metabolism. Clinical application: digestive system diseases]. Muto H Nihon Rinsho; 1985 Mar; 43(3):583-6. PubMed ID: 3892089 [No Abstract] [Full Text] [Related]
9. [Action of carbacyclic 13,14-didehydro-analogs of prostacyclin on the contractile activity of the rat stomach muscles]. Kobzar' GT; Lopp MI; Lille IuE Farmakol Toksikol; 1989; 52(3):38-40. PubMed ID: 2507349 [TBL] [Abstract][Full Text] [Related]
10. [Role of prostanoids in the pathogenesis and therapy of peptic ulcer]. Fich A; Stalnikowicz R; Goldin E; Eliakim R; Wengrower D; Ligumsky M; Karmeli F; Rachmilewitz D Harefuah; 1986 Nov; 111(10):292-5. PubMed ID: 3817615 [No Abstract] [Full Text] [Related]
11. Occurrence of prostaglandin E2 in the human stomach, and a study of its effects on human isolated gastric muscle. Bennett A; Murray JG; Wyllie JH Br J Pharmacol Chemother; 1968 Feb; 32(2):339-49. PubMed ID: 4296426 [No Abstract] [Full Text] [Related]
12. Methyl-PGE 2 in the experimental chronic gastric ulcer. Quina M; Sanguino JC; Guerreiro A; Fonseca FC; Baptista A; Mexia JT Med Chir Dig; 1979; 8(2):159-62. PubMed ID: 379467 [No Abstract] [Full Text] [Related]
13. Antisecretory and protective properties of prostaglandin analogs in man. Müller P; Simon B; Dammann HG Dig Dis Sci; 1982 Sep; 27(9):862. PubMed ID: 7115548 [No Abstract] [Full Text] [Related]
14. Effects of E2 prostaglandins on gastric secretion and gastrointestinal mucosa. Johansson C; Kollberg B Scand J Gastroenterol Suppl; 1980; 58():93-7. PubMed ID: 6988944 [No Abstract] [Full Text] [Related]
15. [Mechanisms of the cytoprotective effect of prostaglandins]. Maśliński S; Wojtecka-Lukasik E Acta Physiol Pol; 1983; 34 Suppl 25():53-77. PubMed ID: 6372371 [No Abstract] [Full Text] [Related]
17. Prostaglandins in nephrology. Astoin M; Hornych A; Meyer P Adv Nephrol Necker Hosp; 1974; 4():139-69. PubMed ID: 4219990 [No Abstract] [Full Text] [Related]
18. [Transport processes in the gastric mucosa and their pharmacologic modification]. Blum AL; Fimmel CJ Z Gastroenterol Verh; 1986 Apr; 21():124-8. PubMed ID: 2422828 [No Abstract] [Full Text] [Related]
19. Role of prostaglandins in the control of gastric acid secretion. Peskar BM Hepatogastroenterology; 1980 Aug; 27(4):330-6. PubMed ID: 7009357 [No Abstract] [Full Text] [Related]